Electroretinograms and visual evoked cortical potentials in Parkinsonian patients with or without L-Dopa treatment

References

• Hornykiewicz O. Biochemical abnormalities in some extrastriatal neuron systems in Parkinson's disease. Parkinson's Disease. Current Progress, Problems and Management, U K Rinne, et al. Elsevier/ North Holland Biomedical Press, Amsterdam 1980; 109–119
   Google Scholar
• Javoid-Agid F, Ruberg M, et al. Biochemical neuropathology of Parkinson's disease. Adv Neurol 1984; 40: 189–198
   PubMedGoogle Scholar
• Scatton B, Rouquier L, et al. Dopamine deficiency in the cerebral cortex in Parkinson's disease. Neurology 1982; 32: 1039–1040
   PubMed Web of Science ®Google Scholar
• Ehinger B. Adrenergic retinal neurons. Z Zellforsch 1966; 71: 146–152
   Google Scholar
• Ehinger B. Adrenergic neurons in the retina. Life Sci 1966; 5: 129–131
   PubMedGoogle Scholar
• Dowling J E, Ehinger B. Synaptic organisation of the amine containing interplexiform cells of the goldfish and Cebus monkey retinas. Science 1975; 188: 270–273
   PubMed Web of Science ®Google Scholar
• Dowling J E, Ehinger B. The interplexiform cell system I. Synapses of the dopaminergic neurons of the goldfish retina. Proc Roy Soc Lond B 1978; 201: 7–26
   PubMed Web of Science ®Google Scholar
• Frederick J M, Rayborn M E, et al. Dopaminergic neurons in the human retina. J Comp Neurol 1982; 210: 65–79
   PubMed Web of Science ®Google Scholar
• Nguyen-Legros J, Botteri C, et al. Morphology of primate's dopaminergic amacrine cells as revealed by TU-like immuno-reactivity on retinal flat-mounts. Brain Res 1984; 295: 145–153
   PubMed Web of Science ®Google Scholar
• Bodis-Wollner I, Yahr M D. Measurement of visual evoked potentials in Parkinson's disease. Brain 1978; 101: 661–671
   PubMed Web of Science ®Google Scholar
• Bodis-Wollner I, Yahr M D, et al. Dopaminergic deficiency and delayed visual evoked potentials in humans. Ann Neurol 1982; 11: 478–483
   PubMed Web of Science ®Google Scholar
• Gawel M J, Das P, et al. Visual and auditory evoked responses in patients with Parkinson's disease. J Neurol Neurosurg Psychiat 1981; 44: 227–232
   PubMed Web of Science ®Google Scholar
• Kupersmith M J, Shakin E, et al. Visual system abnormalities in patients with Parkinson's disease. Arch Neurol 1982; 39: 284–286
   PubMedGoogle Scholar
• Tartaglione A, Pizio N, et al. VEP changes in Parkinson's disease are stimulus dependent. J Neurol Neurosurg Psychiat 1984; 47: 305–307
   PubMed Web of Science ®Google Scholar
• Onofrj M, Bodis-Wollner I, et al. Visual evoked potentials in Parkinson's disease and dopamine blockade reveal a stimulus-dependent dopamine function in humans. J Neurol Neurosurg Psychiat 1986; 49: 1150–1159
   PubMed Web of Science ®Google Scholar
• Ehle A L, Stewart, et al. Normal checkerboard pattern reversal evoked potentials in Parkinsonism. Electroenceph Clin Neurophysiol 1982; 54: 336–338
   PubMedGoogle Scholar
• Hansch E C, Syndulko K, et al. Cognition in Parkinson's disease: an event-related potential perspective. Ann Neurol 1982; 11: 599–607
   PubMed Web of Science ®Google Scholar
• Dinner D S, Luders H, et al. Pattern evoked potentials (PEPs) in Parkinson's disease. Neurology 1985; 35: 610–613
   PubMed Web of Science ®Google Scholar
• Cavallacci G, Perossini M. Intérêt clinique du test électrorétinographique dans la maladie de Parkinson. J Fr Ophtalmol 1979; 2: 705–709
   PubMedGoogle Scholar
• Nightingale S, Mitchell K W, Howe J W. Visual evoked potentials and pattern electroretinograms in Parkinson's disease and control subjects. J Neurol Neurosurg Psychiat 1986; 49: 1280–1287
   PubMed Web of Science ®Google Scholar
• Stanzione P, Pierelli F, et al. Pattern visual evoked potentials and electroretinogram abnormalities in Parkinson's disease: effects of L-Dopa therapy. Clin Vision Sci 1989; 4(2)115–127
   Google Scholar
• Sandrini G, Gelmi C, et al. Electroretinographic and visual evoked potential abnormalities in myotonic dystrophy. Electroenceph Clin Neurophysiol 1986; 64: 215–217
   PubMedGoogle Scholar
• Gelmi C, Borgna-Pignatti C, Franchin S, et al. Electroretinographic and visual evoked potential abnormalities in patients with beta-thalassemia major. Ophthalmologica (Basel) 1988; 196: 29–34
   PubMed Web of Science ®Google Scholar
• Brunette J R. Electroretinographic study of the rod-cone break in the dark adaptation curve in man. Am J Ophthalmol 1971; 63: 22
   Google Scholar
• Cajal S R. Histologic du système nerveux de ľhomme et des mammifères. Consejo Superior de Investigaciones Cientifi-cas, Madrid 1972
   Google Scholar
• Malforms T. Evidence of adrenergic neurons with synaptic terminals in the retina of rats demonstrated with fluorescence and electron microscopy. Acta Physiol Scand 1963; 58: 99–100
   PubMedGoogle Scholar
• Nguyen-Legros J. Les neurones dopaminergiques de la rétine. J Fr Ophtalmol 1984; 7(3)245–258
   PubMedGoogle Scholar
• Borbe H O, Fehske K J, et al. The demonstration of several neurotransmitters and drug receptors in human retina. Comp Biochem Physiol 1982; 72: 117–119
   Google Scholar
• Citron M C, Erinoff L, et al. Modifications of electroretinograms in dopamine-depleted retinas. Brain Res 1985; 345: 186–191
   PubMed Web of Science ®Google Scholar
• Maclin E L, Bodis-Wollner I, Marx M. Simultaneous pattern electroretinograms and VEPs in MTPT-treated monkeys. Invest Ophthalmol Vis Sci 1985; 26: 68
   PubMedGoogle Scholar
• Hempel F G. Modification of the rabbit electroretinogram by reserpine. Ophthalmic Res 1973; 4: 227–232
   Web of Science ®Google Scholar
• Dehon P. Exploration électrophysiologique de la rétine: ERG et EOG normaux et pathologiques. J Fr Ophtalmol 1978; 4(5)323–338; 399–414
   Google Scholar
• Nguyen-Legros J. Functional neuroarchitecture of the retina: hypothesis on the dysfunction of retinal dopaminergic circuitry in Parkinson's disease. Surg Radiol Anat 1988; 10: 137–144
   PubMed Web of Science ®Google Scholar
• Gottlob I, Schneider E, Heider W, Skarandies W. Alteration of visual evoked potentials and electroretinograms in Parkinson's disease. Electroenceph Clin Neurophysiol 1987; 66: 349–357
   PubMedGoogle Scholar
• Dyer R S, Howell W E, McPhail R C. Dopamine depletion slows retinal transmission. Exp Neurol 1981; 71: 326–340
   PubMed Web of Science ®Google Scholar
• Bhaskar P A, Vanchiligam S, et al. Effect of L-Dopa on visual evoked potentials in patients with Parkinson's disease. Neurology 1986; 36: 1119–1121
   PubMed Web of Science ®Google Scholar
• Economou S G, Stefanis C N. Changes of electrooculogram (EOG) in Parkinson's disease. Acta Neurol Scand 1978; 58: 44–52
   PubMed Web of Science ®Google Scholar
• Wong C, Ishibashi T, Tucker G, et al. Responses of the pigmented rabbit retina to NMPTP, a chemical inducer of Parkinsonism. Exp Eye Res 1986; 40: 509–519
   Web of Science ®Google Scholar
• Jagadeesh J M, Lee H C, Salazar-Bookaman M. Influence of chloropromazine on the rabbit electroretinogram. Invest Ophthalmol Vis Sci 1980; 19: 1449
   PubMed Web of Science ®Google Scholar
• Jagadeesh J M, Sanchez R. Effects of apomorphine on the rabbit electroretinogram. Invest Ophthalmol Vis Sci 1980; 21: 620–625
   Web of Science ®Google Scholar